Evidence map›Paper›PMID 31817803›Full record

ArticleGenes2019

The Impact of Genetic Variations in ADORA2A in the Association between Caffeine Consumption and Sleep.

Mégane Erblang, Catherine Drogou, Danielle Gomez-Merino, Arnaud Metlaine, Anne Boland, Jean François Deleuze, Claire Thomas, Fabien Sauvet, Mounir Chennaoui

Open access · goldAbstract read
In one paragraph

Article in Genes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. TheNutrients · 2023
    Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Review
  12. Habitual caffeine intake, genetics and cognitive performance.Journal of psychopharmacology (Oxford, England) · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. [Recent research on gene polymorphisms related to caffeine therapy in preterm infants with apnea of prematurity].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Mégane ErblangUnité Fatigue et Vigilance, Institut de recherche biomédicale des armées (IRBA), EA 7330 VIFASOM, Université de Paris, 75004 Paris, France.
Catherine DrogouUnité Fatigue et Vigilance, Institut de recherche biomédicale des armées (IRBA), EA 7330 VIFASOM, Université de Paris, 75004 Paris, France.
Danielle Gomez-MerinoUnité Fatigue et Vigilance, Institut de recherche biomédicale des armées (IRBA), EA 7330 VIFASOM, Université de Paris, 75004 Paris, France.
Arnaud MetlaineEA 7330 VIFASOM, Université de Paris, APHP, Hôtel Dieu, Centre du Sommeil et de la Vigilance, 75004 Paris, France.
Anne BolandCentre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, Université Paris-Saclay, 91057 Evry, France.
Jean François DeleuzeCentre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, Université Paris-Saclay, 91057 Evry, France.
Claire ThomasUnité de Biologie Intégrative des Adaptations à l'Exercice, Université Evry, Université, Paris-Saclay, 91025 Evry, France.
Fabien SauvetUnité Fatigue et Vigilance, Institut de recherche biomédicale des armées (IRBA), EA 7330 VIFASOM, Université de Paris, Paris, France.
Mounir ChennaouiUnité Fatigue et Vigilance, Institut de recherche biomédicale des armées (IRBA), EA 7330 VIFASOM, Université de Paris, Paris, France.
Université Paris Cité · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRUniversité Paris-Saclay · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ADORA2A has been shown to be responsible for the wakefulness-promoting effect of caffeine and the 1976T>C genotype (SNP rs5751876, formerly 1083T>C) to contribute to individual sensitivity to caffeine effects on sleep. We investigate the association between six single nucleotide polymorphisms (SNP) from ADORA2A and self-reported sleep characteristics and caffeine consumption in 1023 active workers of European ancestry aged 18-60 years. Three groups of caffeine consumers were delineated: low (0-50 mg/day, less than one expresso per day), moderate (51-300 mg/day), and high (>300 mg/day). We found that at caffeine levels higher than 300 mg/day, total sleep time (TST) decreased (

Indexed as

AllelesPolymorphism, Single NucleotideAdolescentAdultCaffeineFemaleHumansLinkage DisequilibriumMaleMiddle AgedReceptor, Adenosine A2ASleepSleep Initiation and Maintenance DisordersADORA2A protein, humanCaffeineReceptor, Adenosine A2Aadenosine A2A receptorADORA2Acaffeinepolymorphismssleep

Identifiers

PMID31817803
PMCPMC6947650
OpenAlexW2991806204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.